Literature DB >> 21128022

Risk stratification of medulloblastoma: a paradigm for future childhood brain tumor management strategies.

Roger J Packer1.   

Abstract

Entities:  

Year:  2011        PMID： 21128022     DOI： 10.1007/s11910-010-0168-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  9 in total

1.  Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

Authors:  Roger J Packer; Amar Gajjar; Gilbert Vezina; Lucy Rorke-Adams; Peter C Burger; Patricia L Robertson; Lisa Bayer; Deborah LaFond; Bernadine R Donahue; MaryAnne H Marymont; Karin Muraszko; James Langston; Richard Sposto
Journal:  J Clin Oncol       Date:  2006-09-01       Impact factor: 44.544

2.  Prediction of central nervous system embryonal tumour outcome based on gene expression.

Authors:  Scott L Pomeroy; Pablo Tamayo; Michelle Gaasenbeek; Lisa M Sturla; Michael Angelo; Margaret E McLaughlin; John Y H Kim; Liliana C Goumnerova; Peter M Black; Ching Lau; Jeffrey C Allen; David Zagzag; James M Olson; Tom Curran; Cynthia Wetmore; Jaclyn A Biegel; Tomaso Poggio; Shayan Mukherjee; Ryan Rifkin; Andrea Califano; Gustavo Stolovitzky; David N Louis; Jill P Mesirov; Eric S Lander; Todd R Golub
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

Review 3.  Medulloblastoma: clinical and biologic aspects.

Authors:  R J Packer; P Cogen; G Vezina; L B Rorke
Journal:  Neuro Oncol       Date:  1999-07       Impact factor: 12.300

4.  Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

Authors:  R D Kortmann; J Kühl; B Timmermann; U Mittler; C Urban; V Budach; E Richter; N Willich; M Flentje; F Berthold; I Slavc; J Wolff; C Meisner; O Wiestler; N Sörensen; M Warmuth-Metz; M Bamberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

5.  Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

Authors:  Stefan Rutkowski; Udo Bode; Frank Deinlein; Holger Ottensmeier; Monika Warmuth-Metz; Niels Soerensen; Norbert Graf; Angela Emser; Torsten Pietsch; Johannes E A Wolff; Rolf D Kortmann; Joachim Kuehl
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

6.  Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.

Authors:  Amar Gajjar; Roberto Hernan; Mehmet Kocak; Christine Fuller; Youngsoo Lee; Peter J McKinnon; Dana Wallace; Ching Lau; Murali Chintagumpala; David M Ashley; Stewart J Kellie; Larry Kun; Richard J Gilbertson
Journal:  J Clin Oncol       Date:  2004-02-17       Impact factor: 44.544

7.  Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.

Authors:  Stefan Pfister; Marc Remke; Axel Benner; Frank Mendrzyk; Grischa Toedt; Jörg Felsberg; Andrea Wittmann; Frauke Devens; Nicolas U Gerber; Stefan Joos; Andreas Kulozik; Guido Reifenberger; Stefan Rutkowski; Otmar D Wiestler; Bernhard Radlwimmer; Wolfram Scheurlen; Peter Lichter; Andrey Korshunov
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

8.  Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study.

Authors:  Roger J Packer; James G Gurney; Judy A Punyko; Sarah S Donaldson; Peter D Inskip; Marilyn Stovall; Yutaka Yasui; Ann C Mertens; Charles A Sklar; H Stacy Nicholson; Lonnie K Zeltzer; Joseph P Neglia; Leslie L Robison
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 50.717

9.  Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.

Authors:  Marcel Kool; Jan Koster; Jens Bunt; Nancy E Hasselt; Arjan Lakeman; Peter van Sluis; Dirk Troost; Netteke Schouten-van Meeteren; Huib N Caron; Jacqueline Cloos; Alan Mrsić; Bauke Ylstra; Wieslawa Grajkowska; Wolfgang Hartmann; Torsten Pietsch; David Ellison; Steven C Clifford; Rogier Versteeg
Journal:  PLoS One       Date:  2008-08-28       Impact factor: 3.240
  9 in total
  6 in total

1.  Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.

Authors:  David W Ellison; James Dalton; Mehmet Kocak; Sarah Leigh Nicholson; Charles Fraga; Geoff Neale; Anna M Kenney; Dan J Brat; Arie Perry; William H Yong; Roger E Taylor; Simon Bailey; Steven C Clifford; Richard J Gilbertson
Journal:  Acta Neuropathol       Date:  2011-01-26       Impact factor: 17.088

2.  Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma.

Authors:  Xiumei Zhao; Zhigang Liu; Litian Yu; Yujing Zhang; Patricia Baxter; Horatiu Voicu; Sivashankarappa Gurusiddappa; Joseph Luan; Jack M Su; Hon-chiu Eastwood Leung; Xiao-Nan Li
Journal:  Neuro Oncol       Date:  2012-03-29       Impact factor: 12.300

Review 3.  Medulloblastomics: the end of the beginning.

Authors:  Paul A Northcott; David T W Jones; Marcel Kool; Giles W Robinson; Richard J Gilbertson; Yoon-Jae Cho; Scott L Pomeroy; Andrey Korshunov; Peter Lichter; Michael D Taylor; Stefan M Pfister
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

4.  Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines.

Authors:  Lenisa Geron; Karina Bezerra Salomão; Kleiton Silva Borges; Augusto Faria Andrade; Carolina Alves Pereira Corrêa; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Cytotechnology       Date:  2018-10-29       Impact factor: 2.058

Review 5.  Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact.

Authors:  Nicholas S Phillips; Elizabeth S Duke; Hannah-Lise T Schofield; Nicole J Ullrich
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

6.  Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma.

Authors:  Peter S Harris; Sujatha Venkataraman; Irina Alimova; Diane K Birks; Ilango Balakrishnan; Brian Cristiano; Andrew M Donson; Adrian M Dubuc; Michael D Taylor; Nicholas K Foreman; Philip Reigan; Rajeev Vibhakar
Journal:  Mol Cancer       Date:  2014-03-24       Impact factor: 27.401
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.